Search
for
Sort by
Research 121–150 of 1000+
- Hair Loss and Androgen’s Role in the Era of COVID-19
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Androgens in SARS-CoV-2 Coronavirus Infections
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- Local synthesis and function of neuro-estrogen and neuro-androgen: impact on the hippocampus-related cognition and neuronal plasticity
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- 9 Role of 5α-reductase in health and disease
- A Case of Gynecomastia Induced by Use of Doxazosin
- Endocrine disorders and hormonal therapy for adolescent acne
- Treatment guidelines in adult women
- Alopecia: managing the basics
- Androgenic Effects on Ventricular Repolarization
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY